Font: Financial Modeling Prep • May 19, 2026
Eagle Materials (NYSE:EXP) is a leading U.S. manufacturer of basic construction materials. The company's primary products include gypsum wallboard and cement, which are essential for the building industry. In its latest financial release for the fourth quarter and fiscal year 2026, Eagle Materials shows a strong performance against market expectations.
Before the market opens, Eagle Materials reports earnings of $1.91 per share for its fourth quarter. This figure significantly beats the Zacks Consensus Estimate of $1.47 per share by more than 30%. While this is a strong beat against forecasts, it does represent a decrease from the $2.08 per share earned in the same quarter last year.
The company also posts record revenue of $479.1 million for the quarter, marking a 2% increase from the prior year. As highlighted by Zacks, this result surpasses Wall Street's consensus estimate of approximately $456.2 million by over 5%. For the full fiscal year, Eagle Materials achieves a record revenue of $2.3 billion.
The company’s financial health shows a Price-to-Earnings (P/E) ratio of 14.84. This ratio helps investors see the stock's price relative to its earnings. A Debt-to-Equity ratio of 1.02 indicates its financial leverage, showing the company holds slightly more debt than equity, which is common in capital-intensive industries.
Despite revenue growth, net earnings for the quarter decline by 10% to $60.2 million. Throughout the fiscal year, Eagle Materials returns value to its investors by repurchasing 1.7 million of its own shares for $382 million. This action can help increase the value of the remaining shares.
|
TZA§>
Direxion Daily Small Cap Bear 3X ETF
|
$4.83
-7.29%
|
|
SLXN§>
Silexion Therapeutics Ltd.
|
$0.53
96.95%
|
|
HAO§>
Haoxi Health Technology Limited
|
$0.01
0.71%
|
|
SOXS§>
Direxion Daily Semiconductor Bear 3X ETF
|
$8.54
-14.00%
|
|
MEHA§>
Functional Brands, Inc. Common Stock
|
$0.09
21.95%
|
|
JUNS§>
Jupiter Neurosciences, Inc.
|
$0.21
-35.94%
|
|
PHGE§>
BiomX Inc.
|
$0.60
59.60%
|
|
WOK§>
WORK Medical Technology Group Ltd.
|
$0.19
-19.57%
|
|
HCWB§>
HCW Biologics Inc.
|
$2.43
129.25%
|
|
GDC§>
GD Culture Group Limited
|
$0.12
-17.44%
|